Big Data Genetics Protein 
Worldwide Clinical Trials
APRIL 7, 2025
Solid tumors exhibit genetic variances between patients with a shared diagnosis and within a single patient, even across one tumor. Proactively Address Key Recruitment Challenges in Solid Tumor Clinical Research Solid tumor clinical research is challenging, especially because of tumor heterogeneity.
Roots Analysis
JANUARY 28, 2024
Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 16, 2022
A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”. Kim recognised then, he said, that better tools for medicine needed to be developed, and that they still do.
Delveinsight
AUGUST 18, 2021
percent of the population (approximately 5 million people) are at increased risk of Type 2 Diabetes with an HbA1c ( as per the Diabetes UK, based on data from the Health Survey for England). Several genetic and lifestyle factors are observed to be the factors for the development of Type 2 diabetes. Similarly, in the UK, around 10.7
pharmaphorum
SEPTEMBER 18, 2020
The same year, AZ also entered into its third collaboration agreement with Astex Therapeutics, this time to develop small-molecule protein kinase B (PKB) to further contribute in the fight against cancer. AstraZeneca’s first acquisition following its creation was of KuDOS Pharmaceuticals, a UK biotech company, for £120 million in 2005.
Expert insights. Personalized for you.
100 
Let's personalize your content